£61.7M
The Series D round was backed by strategic investors including AstraZeneca, HAT SGR, Hitachi Ventures, and Leaps by Bayer.
Huma develops digital health platforms to advance decentralized care and medical research.
Global healthcare AI company that provides regulated digital health platforms for care and research. Its technology supports thousands of hospitals and clinics worldwide.
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from Huma's latest Companies House filing — with year-on-year movement, free with a Winfred account.
The Series D round was backed by strategic investors including AstraZeneca, HAT SGR, Hitachi Ventures, and Leaps by Bayer.